Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer

Clinical trial NCT04938869 · COMPLETED

Trial details

NCT number: NCT04938869
Sponsor: Ohio State University Comprehensive Cancer Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hematopoietic and Lymphoid System Neoplasm Malignant Solid Neoplasm Type 2 Diabetes Mellitus

Start date: 2021-10-05
Primary completion: 2022-02-17
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.